Exelixis (EXEL) Gross Margin (2012 - 2026)
Exelixis' (EXEL) quarterly Gross Margin came in at 96.73% in Q2 2026, up 18.0% year-on-year from 81.98% in Q2 2025, and up 1.21% quarter-over-quarter from 95.58% in Q1 2026.
Exelixis (EXEL) Gross Margin (2012 - 2026) Analysis & Trends
Exelixis' Gross Margin history runs 15 years deep, the most recent figure standing at 96.73% for Q2 2026.
- On a quarterly basis, Gross Margin rose 18.0% year-over-year to 96.73% in Q2 2026; TTM through Apr 2026 was 96.44%, a 33.0% decrease from a year earlier, with the FY2026 full-year figure at 96.39%, down 9.0% from the prior year.
- Gross Margin grew to 96.73% in Q2 2026 per EXEL's latest filing, from 95.58% in the prior quarter.
- Across five years, Gross Margin topped out at 97.23% in Q2 2024 and bottomed at 95.0% in Q1 2024.
- The 5-year median for Gross Margin is 96.48% (2025), against an average of 96.33%.
- Across the five-year window, Gross Margin sank 150 bps in 2024 and surged 155 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 96.24% in 2022, then dropped by 1 bps to 95.46% in 2023, then grew by 1 bps to 96.79% in 2024, then gained by 0 bps to 96.89% in 2025, then declined by 0 bps to 96.73% in 2026.
- Per Business Quant, the three latest EXEL Gross Margin figures stand at 96.73% (Q2 2026), 95.58% (Q1 2026), and 96.89% (Q4 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 96.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 96.73% |
| Jan 2, 2026 | 95.58% |
| Oct 3, 2025 | 96.89% |
| Jul 4, 2025 | 96.57% |
| Apr 4, 2025 | 96.55% |
| Jan 3, 2025 | 96.48% |
| Sep 27, 2024 | 96.79% |
| Jun 28, 2024 | 97.23% |
| Mar 29, 2024 | 95.00% |
| Dec 29, 2023 | 95.46% |
| Sep 29, 2023 | 96.02% |
| Jun 30, 2023 | 96.23% |
| Mar 31, 2023 | 96.50% |
| Dec 30, 2022 | 96.24% |
| Sep 30, 2022 | 96.28% |
| Jul 1, 2022 | 96.79% |
| Apr 1, 2022 | 96.29% |
| Oct 1, 2021 | 96.38% |
| Jul 2, 2021 | 96.14% |
| Apr 2, 2021 | 95.12% |